Insulin Resistance
|
phenotype |
Nutritional and Metabolic Diseases
|
Pathologic Function
|
162
|
53
|
0.100 |
None |
|
0 |
|
|
|
insulinoma
|
disease |
Digestive System Diseases; Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
258
|
8
|
0.040 |
None |
1.000 |
4 |
|
2010 |
2019 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Leukemia, Myelocytic, Acute
|
disease |
Neoplasms
|
Neoplastic Process
|
3111
|
6892
|
0.100 |
None |
1.000 |
1 |
9
|
2017 |
2017 |
Multiple Myeloma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases
|
Neoplastic Process
|
1740
|
865
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
MUTYH-Associate Polyposis
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms
|
Neoplastic Process
|
73
|
36
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Generalized Anxiety Disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
103
|
24
|
0.070 |
None |
1.000 |
7 |
|
2010 |
2018 |
Schizophrenia
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
2872
|
2897
|
0.310 |
None |
< 0.001 |
1 |
|
2012 |
2012 |
Hyperactive behavior
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Mental or Behavioral Dysfunction
|
1263
|
112
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Fasting blood glucose measurement
|
phenotype |
|
Laboratory Procedure
|
96
|
212
|
0.100 |
None |
1.000 |
9 |
3
|
2010 |
2019 |
Insulin measurement
|
phenotype |
|
Laboratory Procedure
|
15
|
25
|
0.100 |
None |
1.000 |
2 |
1
|
2011 |
2013 |
Triglycerides measurement
|
phenotype |
|
Laboratory Procedure
|
563
|
1418
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Glucose measurement
|
phenotype |
|
Laboratory Procedure
|
89
|
111
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Autoantibody measurement
|
phenotype |
|
Laboratory Procedure
|
27
|
52
|
0.100 |
None |
1.000 |
1 |
1
|
2009 |
2009 |
Fasting blood sugar result
|
phenotype |
|
Laboratory or Test Result
|
65
|
113
|
0.100 |
None |
1.000 |
2 |
2
|
2012 |
2012 |
elevated blood glucose level
|
phenotype |
|
Finding
|
89
|
111
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Decreased waist to hip ratio
|
phenotype |
|
Finding
|
28
|
|
0.100 |
None |
|
0 |
|
|
|
Diabetes Mellitus, Non-Insulin-Dependent
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
3134
|
2672
|
0.500 |
None |
0.963 |
135 |
12
|
2007 |
2019 |
Diabetes Mellitus, Insulin-Dependent
|
disease |
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
1675
|
954
|
0.100 |
None |
0.954 |
65 |
1
|
2008 |
2019 |
Diabetes Mellitus
|
group |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
2803
|
824
|
0.100 |
None |
0.961 |
51 |
2
|
2008 |
2019 |
Diabetes
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
2359
|
710
|
0.100 |
None |
0.957 |
47 |
2
|
2008 |
2019 |
Autoimmune Diseases
|
group |
Immune System Diseases
|
Disease or Syndrome
|
1758
|
428
|
0.100 |
None |
1.000 |
12 |
1
|
2008 |
2019 |
Gestational Diabetes
|
phenotype |
Nutritional and Metabolic Diseases; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Disease or Syndrome
|
649
|
224
|
0.080 |
None |
1.000 |
8 |
3
|
2009 |
2018 |
Obesity
|
disease |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
2821
|
1111
|
0.040 |
None |
1.000 |
4 |
1
|
2009 |
2019 |